Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-26 · accession 0000874716-26-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-26 | IDXX | Hunt Nimrata | EVP | S - Sale | $661.54 | -2,693 | 19.9K | -12% | -$1.78M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | S | D | 2,693 | $661.54 | 19,898.94 | D | — | — | (F1) Represents the weighted average price of the shares sold ranging from a low of $661.35 to a high of $661.8275 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |